arginyl-glycyl-aspartic acid has been researched along with Hypoxia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matthey, M; Welschoff, J; Wenzel, D | 1 |
| Chang, YS; Cheon, GJ; Chung, JK; Hong, MK; Jeong, JM; Kim, YJ; Lee, DS; Lee, MC; Lee, YS | 1 |
| Bretzel, RG; Brownlee, M; Chavakis, E; Hammes, HP; Linn, T; Preissner, KT; Riecke, B | 1 |
| Gao, G; Kaufman, PL; Ma, JX; Saunders, RA; Zhang, D | 1 |
1 trial(s) available for arginyl-glycyl-aspartic acid and Hypoxia
| Article | Year |
|---|---|
Topical application of integrin antagonists inhibits proliferative retinopathy.
Topics: Adhesiveness; Administration, Topical; Animals; Diabetic Retinopathy; Hypoxia; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Oligopeptides; Ophthalmic Solutions; Receptors, Vitronectin; Retina | 2001 |
3 other study(ies) available for arginyl-glycyl-aspartic acid and Hypoxia
| Article | Year |
|---|---|
RGD peptides induce relaxation of pulmonary arteries and airways via β3-integrins.
Topics: Animals; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Heart Ventricles; Hypoxia; In Vitro Techniques; Integrin beta3; Lung; Mice; Nitric Oxide Synthase Type III; Oligopeptides; Perfusion; Potassium Channels; Pulmonary Artery; Signal Transduction; Vasodilation | 2014 |
Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
Topics: Animals; Coordination Complexes; Feasibility Studies; Gallium Radioisotopes; Heterocyclic Compounds; Hindlimb; Humans; Hypoxia; Ischemia; Isothiocyanates; Male; Mice; Neovascularization, Pathologic; Oligopeptides; Positron-Emission Tomography; Staining and Labeling; Transplantation, Heterologous | 2008 |
Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.
Topics: Angiogenesis Inhibitors; Animals; Capillaries; Cell Count; Cells, Cultured; Endothelium, Vascular; Humans; Hypoxia; Injections; Kringles; Neovascularization, Pathologic; Oligopeptides; Oxygen; Peptide Fragments; Plasminogen; Rats; Rats, Inbred BN; Rats, Sprague-Dawley; Recombinant Proteins; Reference Values; Retina; Retinal Diseases; Retinal Vessels; Vitreous Body | 2001 |